Stephanie Bertolin
A5035614137- Mechanical Circulatory Support Devices
- Cardiac Arrest and Resuscitation
- Cardiac Structural Anomalies and Repair
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
- Heart Failure Treatment and Management
- Cardiac Valve Diseases and Treatments
- Inflammatory Biomarkers in Disease Prognosis
- Long-Term Effects of COVID-19
- Cardiac and Coronary Surgery Techniques
- Sepsis Diagnosis and Treatment
- COVID-19 and healthcare impacts
- Respiratory Support and Mechanisms
Azienda Ospedaliera Nazionale SS. Antonio e Biagio e Cesare Arrigo
2022-2025
Policlinico San Matteo Fondazione
2024
Istituti di Ricovero e Cura a Carattere Scientifico
2024
Università degli Studi del Piemonte Orientale “Amedeo Avogadro”
2020-2021
Azienda Ospedaliero Universitaria Maggiore della Carita
2021
Abstract Clinical features and natural history of coronavirus disease 2019 (COVID-19) differ widely among different countries during phases the pandemia. Here, we aimed to evaluate case fatality rate (CFR) identify predictors mortality in a cohort COVID-19 patients admitted three hospitals Northern Italy between March 1 April 28, 2020. All these had confirmed diagnosis SARS-CoV-2 infection by molecular methods. During study period 504/1697 died; thus, overall CFR was 29.7%. We looked for...
The present analysis from the multicentre prospective Altshock-2 registry aims to better define clinical features, in-hospital course, and management of cardiogenic shock complicating acutely decompensated heart failure (ADHF-CS) as compared with that acute myocardial infarction (AMI-CS).All patients AMI-CS or ADHF-CS enrolled in between March 2020 February 2022 were selected. primary objective was characterization AMI-CS. In-hospital length stay mortality secondary endpoints....
Introduction. The clinical course of Coronavirus Disease 2019 (COVID-19) is highly heterogenous, ranging from asymptomatic to fatal forms. identification and laboratory predictors poor prognosis may assist clinicians in monitoring strategies therapeutic decisions. Materials Methods. In this study, we retrospectively assessed the prognostic value a simple tool, complete blood count, on cohort 664 patients ( <math xmlns="http://www.w3.org/1998/Math/MathML" id="M1"> <mi>F</mi> </math> 260; 39%,...
Abstract Background Cardiogenic shock (CS) is a leading complication of acute myocardial infarction (AMI), accounting for significant mortality and morbidity. Temporary mechanical circulatory support (t-MCS) has recently emerged as valuable option CS treatment, also serving crucial backup high-risk percutaneous coronary interventions (PCI). DanGer Shock Trial was the first to show superiority Impella CP over standard-of-care treatment in this setting. The role 5.0/5.5 such complex framework...
Aims To describe the use and relation to outcome of different ventilation strategies in a contemporary, large, prospective registry cardiogenic shock patients. Methods results Among 657 patients enrolled from March 2020 November 2023, 198 (30.1%) received oxygen therapy (OT), 96 (14.6%) underwent non‐invasive (NIV), 363 (55.3%) invasive mechanical (iMV). Patients iMV group were significantly younger compared those NIV OT groups (63 vs. 69 years, p < 0.001). There no significant...
When axillary/subclavian arteries are not suitable because of size or anatomy, alternative access for the Impella pump 5.0/5.5 via innominate artery allows circulatory support and eventually de-escalation from VA-ECMO to isolated left-side support. Moreover, less invasive surgery without need open pericardium reduces risk RV dysfunction bleeding. Finally, upper body strategies allow early rehabilitation during support, which is associated with improved survival in cardiogenic shock.
Abstract Funding Acknowledgements None. Background Respiratory support is a vital component of the comprehensive management cardiogenic shock (CS). However, there lack data comparing application different respiratory modalities in CS patients. Purpose Aim this study was to examine use low-flow oxygen (LFO), non-invasive ventilation (NIV), and invasive mechanical (IMV) cohort patients assess their effects on 60-day mortality. Methods We analyzed enrolled multicenter prospective registry from...
Clear clinical guidelines for the assessment and treatment of right ventricular failure (RVF) remain an unmet need. Although high complexity patients are common in this setting, ideal management remains uncertain, resulting mortality rates despite presumably optimal medical therapy. Timely with Impella RP may offer benefits by supplying circulatory support during acute RVF phase providing time unloading necessary native heart recovery. As such, mastering technicalities ancillary therapies is...